Read our latest advice on Coronavirus (COVID-19)

Our services are open and safe to attend – we are here to help

Wilkins, Bridget – consultant histopathologist

Consultant profiles

Bridget Wilkins - histopathologist



Areas of expertise: diagnostic histopathology specifically bone marrow and lymphoid tissue pathology (haematopathology), quality improvement, leadership skills development, coaching and coach supervision, patient engagement in pathology and ethical and regulatory aspects of tissue use in biomedical research

  • Biography

    Dr Bridget Wilkins is a consultant histopathologist at Guy's and St Thomas' NHS Foundation Trust. She is also:

    • Association of Clinical Pathologists National Leadership Skills programme coordinator
    • Honorary senior lecturer at King's College London

    • Honorary senior lecturer at Imperial College, London, UK.
  • Specialist interests

    Bridget is a researcher in myeloproliferative neoplasms and other aspects of bone marrow physiology and pathology. She has expertise in pathology of the spleen. She is a champion for the seeking of patients’ consent routinely for research using their tissue, and making more active use of diagnostic pathology archives as biobanks. 

    Bridget has held national roles in recent years with the Royal College of Pathologists (promoting quality improvement) and National Cancer Research Institute (promoting pathology research and biobanking). She is also a volunteer internal coach and coach-supervisor for Guy's and St Thomas' and she coaches externally, having qualified to EMCC ‘Coach Practitioner’ level, equivalent to ILM7.

    Her greatest interests in her current post-retirement career lie in supporting others to work at their best through developing their interpersonal (leadership) skills and in mentoring younger colleagues in pathology.

  • Research interests

    Bridget is a pathology champion for biobanking in research. She was instrumental in setting up an Experimental Cancer Medicine Centre (ECMC) networking group of pathologists, to increase the recognition and maximise the scope of pathology contributions to ECMC programmes of translational research. From that, working within the National Cancer Research Institute (NCRI), Bridget established ‘CM-Path’, an ongoing NCRI-funded initiative to reinvigorate academic endeavour within cellular and molecular pathology. She continues to represent CM-Path within the Royal College of Pathologists as a co-opted member of the latter’s research committee.

    Bridget has ongoing direct participation in research into the pathology of myeloproliferative neoplasms, contributing to studies arising from the PT-1 and MAJIC studies in collaboration with professor Claire Harrison in haematology at Guy's and St Thomas', professor Tony Green in Cambridge and professor Adam Mead in Oxford.